Suppr超能文献

急性心肌梗死早期再灌注对程序刺激诱发心律失常的影响:一项前瞻性随机研究。

Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study.

作者信息

Kersschot I E, Brugada P, Ramentol M, Zehender M, Waldecker B, Stevenson W G, Geibel A, De Zwaan C, Wellens H J

出版信息

J Am Coll Cardiol. 1986 Jun;7(6):1234-42. doi: 10.1016/s0735-1097(86)80141-3.

Abstract

This study compares inducibility of ventricular tachyarrhythmias by programmed electrical stimulation of the heart in patients with myocardial infarction with and without reperfusion after streptokinase therapy. Sixty-two consecutive patients admitted with an acute myocardial infarction were randomized to either combined intravenous and intracoronary streptokinase (streptokinase group) or to standard coronary care unit treatment (control group). Thirty-six of the 62 patients (21 patients from the streptokinase and 15 from the control group) with a first myocardial infarction were studied by programmed ventricular stimulation after a mean of 26 +/- 14 days. No patient had a history of antiarrhythmic drug use or documentation of a ventricular arrhythmia before the initial admission. A sustained ventricular arrhythmia was induced in 10 (48%) of the 21 patients randomized to streptokinase therapy and in all 15 (100%) control patients (p less than 0.001). Sustained monomorphic ventricular tachycardia was induced in 6 (29%) and 10 (67%) patients, respectively (p less than 0.05). To terminate an induced arrhythmia, direct current countershock was required in 33% of patients in the streptokinase group and 73% of patients in the control group (p less than 0.02). Seventeen of the 21 patients treated with streptokinase and no control patient had evidence of early reperfusion 200 +/- 70 minutes after the onset of pain. In comparison with patients without early reperfusion, patients in the reperfused group had a lower maximal serum creatine kinase value (p less than 0.01), a shorter time to peak creatine kinase value (p less than 0.001) and a higher angiographic left ventricular ejection fraction (62 versus 45%, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究比较了链激酶治疗后心肌梗死患者再灌注与未再灌注时,经心脏程序性电刺激诱发室性快速心律失常的情况。62例连续收治的急性心肌梗死患者被随机分为静脉和冠状动脉联合应用链激酶组(链激酶组)或标准冠心病监护病房治疗组(对照组)。62例患者中有36例(链激酶组21例,对照组15例)首次发生心肌梗死,在平均26±14天后接受了程序性心室刺激研究。所有患者在初次入院前均无抗心律失常药物使用史或室性心律失常记录。随机接受链激酶治疗的21例患者中有10例(48%)诱发出持续性室性心律失常,而对照组15例患者全部(100%)诱发出持续性室性心律失常(p<0.001)。分别有6例(29%)和10例(67%)患者诱发出持续性单形性室性心动过速(p<0.05)。为终止诱发出的心律失常,链激酶组33%的患者和对照组73%的患者需要直流电除颤(p<0.02)。接受链激酶治疗的21例患者中有17例有早期再灌注证据,对照组无患者有早期再灌注证据,疼痛发作后200±70分钟出现早期再灌注。与未早期再灌注的患者相比,再灌注组患者的血清肌酸激酶峰值较低(p<0.01),达到肌酸激酶峰值的时间较短(p<0.001),血管造影显示的左心室射血分数较高(62%对45%,p<0.01)。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验